Brock University has signed an agreement with The Centre for Drug Research and Development (CDRD) that will allow Brock’s researchers to tap into CDRD’s drug development infrastructure and expertise.
“This agreement could not have come at a better time in Brock’s history,” says John Wilson, director of Innovation and Commercialization in the Office of Research Services.
“With the recent opening of our state-of-the-art research facilities and the development of our BioLinc program, we’re making major inroads in developing and applying our research in industry,” adds Wilson. “This, in turn, creates jobs and vitality for the entire community.”
CDRD, a national, not-for-profit drug development and commercialization centre, specializes in helping scientists develop discoveries that are commercially promising into new medicines and treatments.
By collaborating with CDRD, investigators gain access to project management, commercial analysis and evaluation, other research institutions, researchers working in complementary areas, and specialized scientific equipment and expertise to help get their research into the market.
“We are very pleased to extend our network to Brock University,” says Karimah Es Sabar, CDRD President and CEO. “As a national centre, it is important that we serve researchers throughout the country, and enable great discoveries such as those being made at Brock to be transformed into viable commercial opportunity.”
CDRD will hold a workshop at Brock on Thursday, Feb. 14 to explain more about its services and areas of potential partnerships.